首页> 美国卫生研究院文献>Arab Journal of Urology >The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status

【2h】

The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status

机译：用Bacille Calmette-guérin免疫疗法治疗非肌肉浸润性膀胱癌患者编程细胞死亡蛋白配体1的预后价值：当前状态

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To summarise the current evidence of the significance and prognostic value of programmed cell death protein ligand 1 (PD-L1) expression in patients with non-muscle-invasive bladder cancer (NMIBC) treated with bacille Calmette–Guérin (BCG) immunotherapy.

机译：总结当前用Bacille Calmette-guérin（BCG）免疫疗法治疗的非肌肉侵袭性膀胱癌（NMIBC）患者编程的细胞死亡蛋白配体1（PD-L1）表达的意义和预后价值的现有证据。

著录项

期刊名称 Arab Journal of Urology
作者
Łukasz Nowak; Wojciech Krajewski; Adrian Poterek; Anna Śliwa; Romuald Zdrojowy;
展开▼
作者单位

展开▼
年(卷),期 2021(19),1
年度 2021
页码 67–70
总页数 4
原文格式 PDF
正文语种
中图分类泌尿科学（泌尿生殖系疾病）;小儿泌尿科学;肾疾病;
关键词
Bladder cancer; NMIBC; PD-L1; BCG; immunotherapy;

机译：膀胱癌;nmibc;pd-l1;bcg;免疫疗法;

相似文献

外文文献
中文文献
专利

1. The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status [J] . ?ukasz Nowak, Wojciech Krajewski, Adrian Poterek, Arab Journal of Urology . 2021,第1期

机译：用Bacille Calmette-guérin免疫疗法治疗非肌肉浸润性膀胱癌患者编程细胞死亡蛋白配体1的预后价值：当前状态
2. Long-term prognostic value of the combination of EORTC risk group calculator and molecular markers in non-muscle-invasive bladder cancer patients treated with intravesical Bacille Calmette-Guérin [J] . Sultan S Alkhateeb, Mischel Neill, Sas Bar-Moshe, Urology Annals . 2011,第3期

机译：EORTC风险组计算器和分子标志物联合使用对膀胱内BacilleCalmette-Guérin治疗的非肌肉浸润性膀胱癌患者的长期预后价值
3. Clinical Role of Programmed Cell Death-1 Expression in Patients with Non-muscle-invasive Bladder Cancer Recurring After Initial Bacillus Calmette–Guérin Therapy [J] . Keishiro Fukumoto, Eiji Kikuchi, Shuji Mikami, Annals of surgical oncology . 2018,第8期

机译：编程细胞死亡-1表达在初始芽孢杆菌愈合术后非肌肉侵袭性膀胱癌患者中的临床作用
4. Molecular dynamics of the immune checkpoint Programmed Cell Death Protein I, PD-1: Conformational changes of the BC-loop upon binding of the ligand PD-L1 and the monoclonal antibody nivolumab [C] . Bernhard Roither, Chris Oostenbrink, Wolfgang Schreiner IEEE International Conference on Bioinformatics and Biomedicine . 2019

机译：免疫检查点的分子动力学程序性细胞死亡蛋白I，PD-1：配体PD-L1与单克隆抗体nivolumab结合后BC环的构象变化
5. Pattern of programmed cell death-ligand 1 expression and CD8-positive T-cell infiltration before and after chemoradiotherapy in rectal cancer [D] . Ogura Atsushi, 小倉淳司 2019

机译：直肠癌放化疗前后程序性细胞死亡配体1表达和CD8阳性T细胞浸润的模式
6. Prognostic Value of Programmed Death Ligand-1 Expression on Tumor-Infiltrating Immune Cells in Patients Treated with Cisplatin-Based Combination Adjuvant Chemotherapy Following Radical Cystectomy for Muscle-Invasive Bladder Cancer: A Retrospective Cohort Study [O] . Dong Hyeon Lee, Jae Yong Jeong, Wan Song 2021

机译：编程死亡配体-1对肿瘤浸润性免疫细胞对肌肉侵袭性膀胱切除术治疗的患者肿瘤浸润免疫细胞表达的预后价值：肌肉侵袭性膀胱癌：回顾性队列研究
7. The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status [O] . Łukasz Nowak, Wojciech Krajewski, Adrian Poterek, 2020

机译：用Bacille Calmette-guérin免疫疗法治疗非肌肉浸润性膀胱癌患者编程细胞死亡蛋白配体1的预后价值：当前状态

The prognostic value of programmed cell death protein ligand 1 in patients with non-muscle-invasive bladder cancer treated with bacille Calmette–Guérin immunotherapy: Current status

摘要

著录项

相似文献

相关主题

期刊订阅